nipradilol has been researched along with labetalol in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chin, WP; Imai, S; Nakagawa, Y; Nakahara, H | 1 |
| Imai, S; Nakahara, H; Nakazawa, M; Takeda, K | 1 |
| Mikami, H; Ogihara, T | 1 |
| Kinami, J; Maruyama, K; Nagatomo, T; Sasaki, K; Tsuchihashi, H | 1 |
4 other study(ies) available for nipradilol and labetalol
| Article | Year |
|---|---|
Alpha-blockade and vasodilatation induced by nipradilol, arotinolol and labetalol in pithed rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Clonidine; Decerebrate State; Labetalol; Male; Phenylephrine; Prazosin; Propanolamines; Rats; Rats, Inbred Strains; Vasodilation; Yohimbine | 1985 |
Role of the alpha-adrenergic blocking effect in the acute hypotensive effect of beta-adrenergic blocking drugs with alpha-blocking activities in conscious SHR.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Heart Rate; Hydralazine; Labetalol; Male; Prazosin; Propanolamines; Rats; Rats, Inbred SHR; Time Factors | 1985 |
[Clinical application of adrenoceptor blockers in the treatment of hypertension].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Humans; Hypertension; Labetalol; Prazosin; Propanolamines; Quinazolines | 1989 |
Nipradilol displays a unique pharmacological profile of affinities for the different alpha 1-adrenoceptor subtypes.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Binding, Competitive; Ethanolamines; Guinea Pigs; In Vitro Techniques; Isomerism; Labetalol; Male; Prazosin; Propanolamines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha | 1993 |